Africa: sequence 100,000 species to safeguard biodiversity
By ThankGod Echezona Ebenezer et al.,
Nature
| 03. 15. 2022
Image by James Wiseman on Unsplash
Sleeper fish (Bostrychus africanus) are a staple food in West Africa. Harvesting them provides an important source of income for hundreds of communities across the Gulf of Guinea in the Atlantic Ocean. Yet little is known about the genetics of this fish — information that is crucial to safeguarding its genetic diversity, and to enhancing its resilience in the face of climate change and other pressures.
This situation is all too familiar across Africa. Consider orphan crops, which have a crucial role in regional food security, even though they are not typically traded internationally. More than 50% of these have not had their genomes sequenced — from the fluted pumpkin (Telfairia occidentalis) to the marama bean (Tylosema esculentum). The same is true of more than 95% of the continent’s known endangered species (see ‘Africa’s neglected genomes’).
What’s more, by our estimate, around 70% of the 35 or so projects that have focused on studying, conserving or improving biological diversity in Africa over the past 15 years have been...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...